Journal of Pharmaceutical and Biomedical Sciences

Drug-induced Delirium: A Frequent and Important Matter for Geriatricians

Pietro Gareri, Alberto Castagna, Giovanni Ruotolo, Alfonso Merante, Gaetano Russo, Giovambattista De Sarro

Abstract


Use and abuse of drugs, especially if inappropriate, are among the most frequent causes of delirium in elderly people. This article describes an interesting case report on drug-induced delirium in a 74-year-old woman taking several drugs. She was hospitalised for fall and functional inability to lower limbs. She was affected with hypertension, depression and she had undergone surgery and radiotherapy for breast cancer. She had been complaining cognitive impairment for 2 years. Patient was treated with amlodipine 5 mg, ramipril 5 mg, aspirin 100 mg, chlorimipramine 25 mg twice a day. Brain CT scan and spine MRI pointed out multiple dorsolumbar herniated discs. She was visited by a medical doctor who was a specialist in pain treatment; he prescribed oxycodone/naloxone 5/2.5 mg twice/day. After discharge she complained persistent pain, the specialist in pain
treatment increased oxycodone/naloxone 5/2.5 mg up to 3 times daily. After 1 week, patient suddenly presented hyperactive delirium. She underwent geriatric consulting; tricyclic drug and opioid analgesics were interrupted and started oral haloperidol 1.5 mg and intramuscular citicoline 1000 mg. After 3 days, symptoms had disappeared and patient gradually recovered. The present case report is a typical example of drug-induced delirium. Geriatric competence is closely required when one needs to examine the possible interference among drugs in poly-treated patients affected with several diseases, or for example when a drug is used in this group of patients but is strictly contraindicated.

Keywords


elderly, drug-induced delirium, drug-drug interactions, inappropriate drugs

Full Text:

References


Inouye SK. A practical program for preventing delirium in hospitalized elderly patients. Cleve Clin J Med. 2004;71:890–96.

Leentjens AF, van der Mast RC. Delirium in elderly people: an update. Curr Opin Psychiatry. 2015;18:325–30.

Jain KK. Drug-induced neurological disorders, 3rd ed. Gottingen: Hogrefe; 2011.

Maldonado JR. Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatr Psychiatry. 2013;21(12):1190–222.

Kazmierski J, Banys A, Latek J, Bourke J, Jaszewski R. Cortisol levels and neuropsychiatric diagnosis as markers of postoperative delirium: a prospective cohort study. Crit Care. 2013;17(2):R38.

Gareri P, De Sarro G. Principi e problemi di farmacologia geriatrica. In: Putignano S, Cester A, Gareri P, eds. Geriatria Nel Territorio – unmetodo per i vecchi, per i medici e per il futuro (book chapter). Critical Medicine Publishing s.r.l., Roma; 2012. pp. 361–403.

Gareri P, Lacava R, Castagna A, Corsonello A, De Sarro G, Gratteri S and Gallelli L. Iatrogenic delirium in an elderly patient: when drugs are harmful. J Gerontol Geriat Res. 2014;3:1–2.

Tune LE, Egeli S. Acetylcholine and delirium. Dement Geriatr Cogn Disord. 1999;10:342–4.

Bowen JD, Larson EB. Drug-induced cognitive impairment -defining the problem and finding the solutions. Drugs Aging.1993;3(4):349–57.

Gareri P, Falconi U, De Fazio P, De Sarro P. Conventional and new antidepressant drugs in the elderly. Prog Neurobiol.2000;61:353–96.

Pisani MA, Murphy TE, Araujo KL, Slattum P, Van Ness PH, Inouye SK. Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population. Crit Care Med. 2009;37(1):177–83.

Gareri P, De Fazio P, Cotroneo A, Lacava R, Gallelli L, De Fazio S, De Sarro G. Anticholinergic drug-induced delirium in an elderly Alzheimer’s dementia patient. Arch Gerontol Geriatr. 2007;44(Suppl. 1):199–206.

Secades JJ, Frontera G. CDP-choline: pharmacological and clinical review. Methods Find Exp Clin Pharmacol. 1995;17(Suppl B):1–54.

Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages and doubts for an old drug with new perspectives. Clin Interv Aging. 2015;10:1421–9.

Gareri P, De Fazio P, Stilo M, Ferreri G and De Sarro G. Conventional and atypical antipsychotics in the elderly. Clin Drug Invest. 2003;23(5):287–322.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.